Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2008
11/19/2008EP1991255A1 Coagulation factor x polypeptides with modified activation properties
11/19/2008EP1641451B1 Method for photodynamic inactivation of pathogens using ala
11/19/2008EP1268775B1 The high bone mass gene of 11q13.3
11/19/2008CN101309919A Novel pyrrolidine derivatives as inhibitors of coagulation factor XA
11/19/2008CN101309706A Controlled drug release composition and drug releasing medical device
11/19/2008CN101307109A Mouse-anti-human T lymphocyte CD3 surface antigen monoclonal antibodies, method for preparing same and use
11/19/2008CN101307085A SiRNA and recombination lentivirus from preventing hepcidin from regulating protein and uses thereof
11/19/2008CN101306197A Administration system of plasminogen activator sustained and controlled release preparation, construction and use thereof
11/19/2008CN101306196A Biodegradable nano-particles bonded with hemoglobin and production method thereof
11/19/2008CN101306163A Zhixue shengji powder
11/19/2008CN101306162A Malan styptic powder
11/19/2008CN101306142A Yangxuemeiyan capsule
11/19/2008CN101306131A Duituizidian pill
11/19/2008CN101306118A Xuekangfu pill
11/19/2008CN101306116A Xinnaoqingyu decoction
11/19/2008CN101306101A Medicine for treating thrombus and its preparation method
11/19/2008CN101306098A Chinese medicinal materials orally taken for treating bronchiectasis hemoptysis
11/19/2008CN101306097A Zengkangning tablets quality control method
11/19/2008CN101306093A Decoction for treating esophagus cancer haematemesis
11/19/2008CN101306026A Natural indigo prepared by froth flotation method and its preparation method and device
11/19/2008CN100434072C Medication of possessing function of anti inflammation, for improving rheological property of blood, and restraining thrombosis
11/19/2008CN100434065C Hemostatic preparation for gynecology department
11/19/2008CN100434064C Pharmaceutical composition for treating qi and blood deficiency and its preparation method
11/19/2008CN100434062C Application of L-2-oxathiaazalane-4-carboxylic acid and ester derivative thereof in cosmeceutical product
11/19/2008CN100433990C Application of fructus cannabis protein in preparation of health food for relieving nutritional anemia
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452904 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists
11/18/2008US7452883 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
11/18/2008US7452874 Thrombopoietin mimetics
11/18/2008US7452859 Having serine protease inhibitory activity
11/18/2008US7452723 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
11/18/2008US7452551 Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a perfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image
11/18/2008US7452373 Stent coated with magnesium-based compound for reducing thrombosis
11/18/2008CA2320822C Substituted isoindolones and their use as cyclic gmp modulators in medicaments
11/18/2008CA2138594C Process for preparing clear sera which are stable over a long period
11/18/2008CA1341584C Method of amplifying and detecting nucleic acid sequences
11/13/2008WO2008137787A2 Combination therapy with a compound acting as a platelet adp receptor inhibitor
11/13/2008WO2008137753A2 Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor
11/13/2008WO2008137084A2 Diazaquinolones that inhibit prolyl hydroxylase activity
11/13/2008WO2008137060A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008WO2008135526A1 Carboxylic acid amides as factor xa inhibitors
11/13/2008WO2008135524A2 Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
11/13/2008WO2008135500A1 High concentration factor vii polypeptide formulations comprising an aromatic preservative and an antioxidant
11/13/2008WO2008083678A3 Pharmaceutically active compounds
11/13/2008WO2008081331A3 Enhancing the level of antibody expression by framework re-engineering
11/13/2008WO2008076805B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
11/13/2008WO2008076437A9 Activin-actrii antagonists and uses for increasing red blood cell levels
11/13/2008WO2007102037A3 A PROCESS FOR THE PREPARATION OF POLYMORPH FORM I OF (S)-(+)-METHYL-α-(2-CHLOROPHENYL)-6,7-DYHIDRO-THIENO-[3,2-c]PYRIDINE-5(4H)-ACETATE HYDROGEN SULFATE
11/13/2008WO2005084323A3 Compositions of bio-active compounds from fenugreek seed and methods for producing same
11/13/2008US20080281084 Using charged polymers to enhance solubility of polypeptide in aqueous solutions
11/13/2008US20080280981 Oral dosage form; controlling blood concentration; urogenital disorders; edema; blood coagulation disorders in patient undergoing dental surgery
11/13/2008US20080280970 Deuterium-enriched atorvastatin
11/13/2008US20080280946 Azaindole-Derivatives As Factor Xa Inhibitors
11/13/2008US20080280905 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
11/13/2008US20080280831 Chimeric proteins with phosphatidylserine binding domains
11/13/2008US20080280817 Modified amino acid is N-(-5-chlorosalicyloyl)-8-aminocaprylic acid; active agents are heparin, insulin, parathyroid hormone, calcitonin; cardiovascular disorders
11/13/2008US20080279845 Combination therapy with a compound acting as a platelet adp receptor inhibitor
11/13/2008US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof
11/13/2008CA2688317A1 Use of tp modulators for the treatment of cardiovascular disorders in aspirin sensitive and other populations
11/13/2008CA2686203A1 Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor
11/13/2008CA2685216A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008CA2684722A1 Combination therapy with a compound acting as a platelet adp receptor inhibitor
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/12/2008EP1988885A2 Combination of organic compounds
11/12/2008EP1732918B1 Novel pyrrolidine-3,4-dicarboxamide derivatives
11/12/2008EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
11/12/2008EP1147179B1 Human liver progenitors
11/12/2008CN101304979A Quinazoline derivative and pharmaceutical
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302468A Black-bone chicken sticky rice sweet wine and preparation thereof
11/12/2008CN101301477A Isoquercitrin clathrate and preparation thereof
11/12/2008CN101301475A Peg化因子vii糖型 Peg factor vii sugar type
11/12/2008CN101301453A Chinese patent medicine powder for treating hematopathy
11/12/2008CN101301432A Chinese medicinal composition for treating cerebral hemorrhage
11/12/2008CN101301430A Decoction for treating blood deficiency type neurasthenic
11/12/2008CN101301428A Oral Chinese medicine for treating pyelonephritis with hematuria
11/12/2008CN101301409A Oral Chinese medicine for treating gastric ulcer with haematemesis
11/12/2008CN101301373A Hematopoietic oral liquid and preparation thereof
11/12/2008CN101301364A Externally used Chinese medicine for treating cirrhosis ascites and preparation thereof
11/12/2008CN101301350A Lamioplomis rotate extract oral freeze-dried tablet and preparation thereof
11/12/2008CN101301349A Duanxueliu extract oral freeze-dried tablet and preparation thereof
11/12/2008CN101301340A Oral Chinese medicine for treating colonitis induced hematochezia
11/12/2008CN101301337A Chinese medicine preparation for treating hepatic cirrhosis induced haematemesis
11/12/2008CN101301314A Technique for producing liver extract
11/12/2008CN101301308A Use of DFT in preparing medicament for treating and preventing disseminated intravascular coagulation
11/12/2008CN101301295A Use of compound pachymic acid for preparing medicament
11/12/2008CN101301081A Horseradish tree chawing tablet
11/12/2008CN100432107C Protein for promoting erythrocyte growth factor activity and its use
11/12/2008CN100432102C Blood platelet reinforcing protein and application thereof
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432046C Activator for endogenetic pathway of coagulation and their use for exploring anomalies of coagulation
11/12/2008CN100431602C Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
11/12/2008CN100431593C Chinese medicinal formulation for treating hydrocephalus
11/12/2008CN100431575C Medicine composition for treating cardiac and cerebral vascular diseases
11/12/2008CN100431570C Medicine for treating idiopathy thrombocytopenia peliosis
11/12/2008CN100431567C Use of delphinium glabra plant for preparing drug for stopping pain, hemostasis and anticancer
11/12/2008CN100431550C Universal fresh frozen blood plasma
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449492 Therapeutic agents—I
1 ... 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 ... 671